This Bull Market Indicator called NVDA at $116

Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…

All you have to do is follow this link here

MRSN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 11.80%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $256,846.84

Mersana Therapeutics Insider Trading History Chart

Mersana Therapeutics Share Price & Price History

^$2.22

+0.30 (1.20%)

As of 11/21/2024 10:25 AM ET

Days: 30 | 90 | 365

My #1 Pre IPO Trade for 2025 – NAME and TICKER

From Wyatt Investment Research | Ad

One tiny company... Could quickly become "the next SpaceX." It plans to go public on the NASDAQ. And today you can buy Pre-IPO shares for less than $4.00. Get urgent details inside this free report...

The Next SpaceX Pre-IPO

Mersana Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/28/2024	Mohan Bala	SVP	Sell	1,884	$1.90	$3,579.60	54,731
10/3/2024	Alejandra Carvajal	SVP	Sell	5,598	$1.96	$10,972.08	63,716
10/2/2024	Ashish Mandelia	CAO	Sell	4,855	$2.00	$9,710.00	51,118
10/2/2024	Brian Deschuytner	CFO	Sell	8,089	$2.00	$16,178.00	100,422
9/12/2024	Martin H Jr. Huber	CEO	Sell	50,423	$1.76	$88,744.48	116,327
1/16/2024	Anna Protopapas	Director	Sell	29,399	$2.71	$79,671.29	125,153
1/16/2024	Ashish Mandelia	CAO	Sell	5,025	$2.71	$13,617.75	23,328
1/16/2024	Brian Deschuytner	CFO	Sell	9,327	$2.71	$25,276.17	54,511
1/16/2024	Tushar Misra	SVP	Sell	3,357	$2.71	$9,097.47	17,966
10/26/2023	Mohan Bala	SVP	Sell	1,912	$1.13	$2,160.56	8,733
8/17/2023	Tushar Misra	SVP	Sell	1,908	$1.18	$2,251.44	11,507
4/27/2023	Alejandra Carvajal	SVP	Sell	3,944	$3.89	$15,342.16	20,326
1/17/2023	Anna Protopapas	CEO	Sell	17,346	$5.74	$99,566.04	48,733
1/17/2023	Arvin Yang	SVP	Sell	2,209	$5.74	$12,679.66	30,821
1/17/2023	Ashish Mandelia	VP	Sell	3,575	$5.74	$20,520.50	13,619
1/17/2023	Brian Deschuytner	CFO	Sell	5,131	$5.74	$29,451.94	32,781
1/17/2023	Tushar Misra	CMO	Sell	458	$5.74	$2,628.92	5,930
8/17/2022	Tushar Misra	Insider	Sell	1,879	$7.10	$13,340.90	4,371
6/2/2022	Andrew A. F. Hack	Director	Buy	14,760	$3.20	$47,232.00	8,663,673
5/31/2022	Andrew A. F. Hack	Director	Buy	80,759	$3.28	$264,889.52	8,648,913
5/25/2022	Andrew A. F. Hack	Director	Buy	90,155	$3.17	$285,791.35	8,493,154
5/23/2022	Andrew A. F. Hack	Director	Buy	15,599	$3.35	$52,256.65	8,302,999
5/20/2022	Andrew A. F. Hack	Director	Buy	100,000	$3.46	$346,000.00	8,287,400
5/18/2022	Andrew A. F. Hack	Director	Buy	211,268	$3.35	$707,747.80	8,087,400
5/16/2022	Andrew A. F. Hack	Director	Buy	135,292	$3.10	$419,405.20	7,872,692
4/26/2022	Alejandra Carvajal	Insider	Sell	3,948	$3.69	$14,568.12	9,302
4/12/2022	Andrew A. F. Hack	Director	Buy	598,086	$4.18	$2,499,999.48	7,120,116
2/7/2022	Andrew A. F. Hack	Director	Buy	1,136,363	$4.42	$5,022,724.46
1/18/2022	Ashish Mandelia	VP	Sell	1,982	$5.92	$11,733.44
1/18/2022	Timothy B. Lowinger	Insider	Sell	4,741	$5.92	$28,066.72
12/1/2021	Arvin Yang	Insider	Sell	5,527	$6.81	$37,638.87

My #1 Pre IPO Trade for 2025 – NAME and TICKER

From Wyatt Investment Research | Ad

The Next SpaceX Pre-IPO

SEC Filings (Institutional Ownership Changes) for Mersana Therapeutics (NASDAQ:MRSN)

93.92% of Mersana Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Mersana Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/19/2024	Barclays PLC	494,516	$0.93M	0.0%	+32.7%	0.400%
11/16/2024	Geode Capital Management LLC	2,413,215	$4.56M	0.0%	-3.2%	1.967%
11/15/2024	Barclays PLC	494,516	$0.93M	0.0%	+32.7%	0.403%
11/15/2024	XTX Topco Ltd	347,255	$0.66M	0.0%	+186.0%	0.283%
11/15/2024	Wellington Management Group LLP	618,305	$1.17M	0.0%	+16.0%	0.504%
11/15/2024	State Street Corp	2,725,394	$5.15M	0.0%	+1.6%	2.222%
11/15/2024	Quarry LP	30,000	$57K	0.0%	N/A	0.024%
11/15/2024	Jacobs Levy Equity Management Inc.	993,046	$1.88M	0.0%	+104.5%	0.809%
11/15/2024	Atom Investors LP	24,661	$47K	0.0%	-93.3%	0.020%
11/14/2024	Verition Fund Management LLC	1,303,249	$2.46M	0.0%	+11,695.2%	1.062%
11/14/2024	Acuta Capital Partners LLC	1,200,000	$2.27M	1.8%	-27.8%	0.978%
11/14/2024	MetLife Investment Management LLC	33,916	$64K	0.0%	-48.3%	0.028%
11/13/2024	BNP Paribas Financial Markets	237,198	$0.45M	0.0%	-29.4%	0.193%
11/13/2024	FMR LLC	277,740	$0.53M	0.0%	+13.2%	0.226%
11/13/2024	Dynamic Technology Lab Private Ltd	18,095	$34K	0.0%	N/A	0.015%
11/12/2024	HealthInvest Partners AB	538,621	$1.02M	0.5%	+191.3%	0.439%
11/9/2024	Intech Investment Management LLC	27,342	$52K	0.0%	N/A	0.022%
11/5/2024	GSA Capital Partners LLP	271,774	$0.51M	0.0%	+368.9%	0.222%
11/4/2024	Los Angeles Capital Management LLC	189,660	$0.36M	0.0%	+8.1%	0.155%
10/28/2024	US Bancorp DE	16,178	$31K	0.0%	N/A	0.013%
10/10/2024	Exchange Traded Concepts LLC	85,006	$0.16M	0.0%	+95.8%	0.069%
10/3/2024	SG Americas Securities LLC	87,233	$0.17M	0.0%	-37.1%	0.071%
8/16/2024	Algert Global LLC	44,655	$90K	0.0%	N/A	0.036%
8/15/2024	Susquehanna Fundamental Investments LLC	308,691	$0.62M	0.0%	+31.9%	0.252%
8/15/2024	Affinity Asset Advisors LLC	767,000	$1.54M	0.2%	-23.3%	0.627%
8/14/2024	Squarepoint Ops LLC	252,804	$0.51M	0.0%	N/A	0.207%
8/14/2024	Marshall Wace LLP	176,029	$0.35M	0.0%	+358.0%	0.144%
8/12/2024	XTX Topco Ltd	121,432	$0.24M	0.0%	+262.1%	0.099%
8/9/2024	Renaissance Technologies LLC	1,448,219	$2.91M	0.0%	+1.4%	1.184%
8/9/2024	Dimensional Fund Advisors LP	13,703	$28K	0.0%	-56.1%	0.011%
8/8/2024	Federated Hermes Inc.	185,507	$0.37M	0.0%	+105,301.7%	0.152%
8/7/2024	ClariVest Asset Management LLC	500,498	$1.01M	0.1%	+6.1%	0.409%
8/6/2024	Acadian Asset Management LLC	71,506	$0.14M	0.0%	-84.8%	0.058%
8/6/2024	Los Angeles Capital Management LLC	175,420	$0.35M	0.0%	-11.0%	0.143%
7/29/2024	Principal Financial Group Inc.	18,278	$37K	0.0%	-42.5%	0.015%
7/26/2024	Bank of New York Mellon Corp	452,829	$0.91M	0.0%	+19.6%	0.370%
7/12/2024	SG Americas Securities LLC	138,722	$0.28M	0.0%	+313.9%	0.113%
5/17/2024	Walleye Trading LLC	31,526	$0.14M	0.0%	N/A	0.026%
5/16/2024	California State Teachers Retirement System	11,145	$50K	0.0%	-38.9%	0.009%
5/16/2024	Jacobs Levy Equity Management Inc.	809,879	$3.63M	0.0%	-13.0%	0.662%
5/15/2024	Price T Rowe Associates Inc. MD	79,932	$0.36M	0.0%	+6.6%	0.065%
5/10/2024	Acadian Asset Management LLC	468,923	$2.10M	0.0%	+166.7%	0.387%
5/10/2024	Vanguard Group Inc.	6,274,370	$28.11M	0.0%	+0.6%	5.172%
5/8/2024	Russell Investments Group Ltd.	9,453	$42K	0.0%	+976.7%	0.008%
5/7/2024	Susquehanna Fundamental Investments LLC	234,116	$1.05M	0.0%	N/A	0.193%
5/7/2024	ClariVest Asset Management LLC	471,848	$2.11M	0.2%	N/A	0.389%
5/7/2024	SG Americas Securities LLC	33,513	$0.15M	0.0%	-14.6%	0.028%
5/1/2024	BNP Paribas Financial Markets	80,735	$0.36M	0.0%	+90.0%	0.067%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	54,127	$0.23M	0.0%	N/A	0.045%
4/23/2024	Hunter Perkins Capital Management LLC	15,000	$67K	0.0%	-41.6%	0.012%
2/20/2024	Readystate Asset Management LP	295,038	$0.68M	0.0%	N/A	0.244%
2/13/2024	Tower Research Capital LLC TRC	24,533	$57K	0.0%	-49.2%	0.020%
2/13/2024	Affinity Asset Advisors LLC	1,000,000	$2.32M	0.4%	-64.9%	0.828%
2/8/2024	Foundations Investment Advisors LLC	102,000	$0.24M	0.0%	N/A	0.085%
2/5/2024	Victory Capital Management Inc.	12,732	$30K	0.0%	N/A	0.011%
1/25/2024	Nisa Investment Advisors LLC	17,643	$41K	0.0%	+479.8%	0.015%
1/18/2024	Hunter Perkins Capital Management LLC	25,700	$60K	0.0%	-30.5%	0.021%
1/12/2024	SG Americas Securities LLC	39,226	$91K	0.0%	-15.9%	0.033%
1/8/2024	Harbor Capital Advisors Inc.	47,472	$0.11M	0.0%	+28.1%	0.039%
1/5/2024	Exchange Traded Concepts LLC	98,729	$0.23M	0.0%	+34.0%	0.082%
11/21/2023	Walleye Capital LLC	2,021,467	$2.57M	0.0%	+1,205.0%	1.676%
11/15/2023	Acuta Capital Partners LLC	99,607	$0.13M	0.1%	N/A	0.083%
11/15/2023	Affinity Asset Advisors LLC	2,850,000	$3.62M	1.0%	N/A	2.364%
11/14/2023	Newtyn Management LLC	700,000	$0.89M	0.2%	N/A	0.581%
11/13/2023	Acadian Asset Management LLC	354,075	$0.45M	0.0%	N/A	0.294%
11/9/2023	Rhenman & Partners Asset Management AB	21,700	$28K	0.0%	-94.6%	0.018%
11/7/2023	Barclays PLC	34,154	$43K	0.0%	-81.7%	0.028%
11/7/2023	Fox Run Management L.L.C.	21,830	$28K	0.0%	N/A	0.018%
11/6/2023	Los Angeles Capital Management LLC	197,470	$0.25M	0.0%	N/A	0.164%
10/31/2023	Panagora Asset Management Inc.	251,793	$0.32M	0.0%	-7.3%	0.209%
10/20/2023	Harbor Capital Advisors Inc.	37,062	$47K	0.0%	+73.7%	0.031%
10/20/2023	Hunter Perkins Capital Management LLC	37,000	$47K	0.0%	N/A	0.031%
10/18/2023	Exchange Traded Concepts LLC	73,694	$94K	0.0%	+381.6%	0.061%
10/13/2023	SG Americas Securities LLC	46,640	$59K	0.0%	N/A	0.039%
8/15/2023	Readystate Asset Management LP	567,300	$1.87M	0.1%	N/A	0.471%
8/15/2023	Sphera Funds Management LTD.	418,562	$1.38M	0.2%	+3,840.9%	0.347%
8/15/2023	Boxer Capital LLC	1,000,000	$3.29M	0.2%	N/A	0.830%
8/14/2023	Bellevue Group AG	5,219,425	$17.17M	0.2%	+21.4%	4.331%
8/14/2023	Rock Springs Capital Management LP	3,403,133	$11.20M	0.3%	-17.1%	2.824%
8/14/2023	Graham Capital Management L.P.	73,744	$0.24M	0.0%	N/A	0.061%
8/11/2023	Pale Fire Capital SE	25,400	$84K	0.0%	N/A	0.021%
8/11/2023	Panagora Asset Management Inc.	271,501	$0.89M	0.0%	+25.6%	0.225%
8/11/2023	Artal Group S.A.	3,029,555	$9.97M	0.3%	+36.7%	2.514%
8/11/2023	E Fund Management Co. Ltd.	18,105	$60K	0.0%	-34.3%	0.015%
8/11/2023	Rhenman & Partners Asset Management AB	400,000	$1.32M	0.1%	+14.3%	0.332%
8/10/2023	Profund Advisors LLC	61,786	$0.20M	0.0%	-31.4%	0.054%
8/8/2023	Candriam S.C.A.	2,415,477	$7.95M	0.1%	-18.5%	2.112%
8/7/2023	Mirabella Financial Services LLP	14,472	$48K	0.0%	N/A	0.013%
7/20/2023	Exchange Traded Concepts LLC	15,301	$50K	0.0%	N/A	0.013%
7/11/2023	Harbor Capital Advisors Inc.	21,339	$70K	0.0%	N/A	0.019%
5/16/2023	Baker BROS. Advisors LP	1,886,115	$7.75M	0.0%	N/A	1.649%
5/12/2023	Sectoral Asset Management Inc.	343,079	$1.41M	0.3%	N/A	0.315%
5/12/2023	Panagora Asset Management Inc.	216,197	$0.89M	0.0%	+13.2%	0.198%
5/12/2023	Profund Advisors LLC	90,095	$0.37M	0.0%	N/A	0.083%
5/12/2023	Rhenman & Partners Asset Management AB	350,000	$1.40M	0.2%	-12.5%	0.321%
5/11/2023	E Fund Management Co. Ltd.	27,578	$0.11M	0.0%	+26.2%	0.025%
5/11/2023	Skandinaviska Enskilda Banken AB publ	58,469	$0.24M	0.0%	-4.7%	0.054%
5/10/2023	Connor Clark & Lunn Investment Management Ltd.	59,051	$0.24M	0.0%	-71.7%	0.054%
5/10/2023	Tekla Capital Management LLC	162,383	$0.67M	0.0%	N/A	0.149%
5/9/2023	Tower Research Capital LLC TRC	23,450	$96K	0.0%	-36.1%	0.021%

Data available starting January 2016

Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet needs. The company develops XMT-1660, a B7-H4-targeted Dolasynthen ADC candidate; and XMT-2056, an immunosynthen ADC. It has research and development collaborations with Janssen Biotech, Inc., Ares Trading S.A., Merck KGaA, and Asana BioSciences, LLC for the development of ADC product candidates. The company was formerly known as Nanopharma Corp. and changed its name to Mersana Therapeutics, Inc. in November 2005. Mersana Therapeutics, Inc. was incorporated in 2001 and is headquartered in Cambridge, Massachusetts.

Today's Range

Now: $2.22

$2.22

50 Day Range

MA: $2.07

$1.77

$2.63

52 Week Range

Now: $2.22

$1.22

$6.28

Volume

230 shs

Average Volume

1,600,162 shs

Market Capitalization

$274.24 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.5

Who are the company insiders with the largest holdings of Mersana Therapeutics?: Mersana Therapeutics' top insider investors include:
Anna Protopapas (Director)
Martin H Jr Huber (CEO)
Brian Deschuytner (CFO)
Alejandra Carvajal (SVP)
Mohan Bala (SVP)
Ashish Mandelia (CAO)
Anna Protopapas (CEO)
Arvin Yang (SVP)
Tushar Misra (SVP)
Ashish Mandelia (VP)
Tushar Misra (CMO)
Learn More about top insider investors at Mersana Therapeutics.
Who are the major institutional investors of Mersana Therapeutics?: Mersana Therapeutics' top institutional shareholders include:
State Street Corp — 2.22%
Geode Capital Management LLC — 1.97%
Verition Fund Management LLC — 1.06%
Acuta Capital Partners LLC — 0.98%
Jacobs Levy Equity Management Inc. — 0.81%
Wellington Management Group LLP — 0.50%
Learn More about top institutional investors of Mersana Therapeutics stock.
Which major investors are selling Mersana Therapeutics stock?: In the previous quarter, MRSN stock was sold by these institutional investors:
Acuta Capital Partners LLC
Atom Investors LP
BNP Paribas Financial Markets
Geode Capital Management LLC
SG Americas Securities LLC
MetLife Investment Management LLC
Wolverine Trading LLC
In the previous year, company insiders that have sold Mersana Therapeutics company stock include:
Anna Protopapas (Director)
Martin H Jr Huber (CEO)
Brian Deschuytner (CFO)
Alejandra Carvajal (SVP)
Mohan Bala (SVP)
Ashish Mandelia (CAO)
Anna Protopapas (CEO)
Learn More investors selling Mersana Therapeutics stock.
Which major investors are buying Mersana Therapeutics stock?: In the last quarter, MRSN stock was bought by institutional investors including:
Verition Fund Management LLC
Jacobs Levy Equity Management Inc.
HealthInvest Partners AB
XTX Topco Ltd
GSA Capital Partners LLP
Barclays PLC
Barclays PLC
Wellington Management Group LLP